Education
About Us
Working with TipRanks
Follow Us
Polynovo Limited (AU:PNV)
ASX:PNV
PNV Stock Chart & Stats
AU$1.26
AU$0.01(0.49%)
At close: 4:00 PM EST
AU$1.26
AU$0.01(0.49%)
Day’s Range― - ―
52-Week RangeAU$0.93 - AU$2.39
Previous CloseN/A
Volume733.50K
Average Volume (3M)3.76M
Market Cap
$970.63M
Enterprise ValueAU$809.11M
Total Cash (Recent Filing)$33.59M
Total Debt (Recent Filing)$17.14M
Price to Earnings (P/E)66.2
Beta2.31
Next Earnings
Mar 03, 2026EPS Estimate
0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding690,843,000
10 Day Avg. Volume2,337,474
30 Day Avg. Volume3,762,337
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.83
Enterprise Value/Revenue6.36
Enterprise Value/Gross Profit10.58
Enterprise Value/Ebitda72.91
Forecast
1Y Price Target
$1.72Price Target Upside36.75% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Polynovo News
PNV FAQ
What was Polynovo Limited’s price range in the past 12 months?
Polynovo Limited lowest share price was AU$0.93 and its highest was AU$2.39 in the past 12 months.
What is Polynovo Limited’s market cap?
Polynovo Limited’s market cap is $970.63M.
When is Polynovo Limited’s upcoming earnings report date?
Polynovo Limited’s upcoming earnings report date is Mar 03, 2026 which is in 134 days.
How were Polynovo Limited’s earnings last quarter?
Polynovo Limited released its earnings results on Aug 25, 2025. The company reported AU$0.006 earnings per share for the quarter, the consensus estimate of AU$0.006 by AU$0.
Is Polynovo Limited overvalued?
According to Wall Street analysts Polynovo Limited’s price is currently Undervalued.
Does Polynovo Limited pay dividends?
Polynovo Limited does not currently pay dividends.
What is Polynovo Limited’s EPS estimate?
Polynovo Limited’s EPS estimate is 0.02.
How many shares outstanding does Polynovo Limited have?
Polynovo Limited has 690,843,000 shares outstanding.
What happened to Polynovo Limited’s price movement after its last earnings report?
Polynovo Limited reported an EPS of AU$0.006 in its last earnings report, expectations of AU$0.006. Following the earnings report the stock price went up 9.091%.
Which hedge fund is a major shareholder of Polynovo Limited?
Currently, no hedge funds are holding shares in AU:PNV
Polynovo Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$1.72 (36.75% Upside)
$1.72 (36.75% Upside)
Blogger Sentiment
Bullish
AU:PNV Sentiment 95%
Sector Average 69%
Sector Average 69%
Insider Transactions
Bought Shares
Worth $204.7K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-47.53%
12-Months-Change
Fundamentals
Return on Equity
16.49%
Trailing 12-Months
Asset Growth
15.63%
Trailing 12-Months
Company Description
Polynovo Limited
Polynovo (PNV) is a medical technology company focused on developing and commercializing innovative products for the healthcare sector, particularly in the fields of wound care and regenerative medicine. The company specializes in biodegradable polymers and its core products include the NovoSorb polymer technology, which is utilized in various applications such as dermal scaffolds, wound dressings, and advanced tissue regeneration solutions. Polynovo aims to improve patient outcomes through its cutting-edge biomedical products while addressing unmet medical needs in the market.
PNV Company Deck
PNV Earnings Call
Q4 2025
0:00 / 0:00
PNV Stock 12 Month Forecast
Average Price Target
AU$1.72
▲(36.75% Upside)
Technical Analysis
Somnomed Limited
―
Cyclopharm Limited
―
Aroa Biosurgery Ltd
―
EMvision Medical Devices Ltd.
―
4DMedical Ltd
―
Options Prices
Currently, No data available
---